33.40 USD
↗ 1.84 (5.83%)AT CLOSE (11:59 AM EDT)
Septerna, Inc. Common Stock
SEPNNASDAQ • USD
33.41
↗ 0.01 (0.03%)
POST MARKET (AS OF 06:26 PM EDT)
Post Market
AS OF 06:26 PM EDT
33.41
↗ 0.01 (0.03%)
Market: CLOSED
Septerna, Inc. Common Stock (SEPN) is currently trading at $33.41. The technical outlook is "Neutral" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. SEPN is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$30.98
High?$34.29
Low?$30.55
Prev. Close?$31.56
Volume?306.4K
Avg. Volume?508.5K
VWAP?$33.21
Rel. Volume?0.60x
Bid / Ask
Bid?$26.25 × 100
Ask?$41.63 × 100
Spread?$15.38
Midpoint?$33.94
Valuation & Ratios
Market Cap?1.4B
Shares Out?45.1M
Float?21.9M
Float %?48.5%
P/E Ratio?N/A
P/B Ratio?3.76
EPS?-$0.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Themes
Employees
130
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-25
Address
250 EAST GRAND AVENUE, SUITE 65
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-338-3533
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-338-3533
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?95
Momentum?73
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?4.37Safe
Confidence?45%Low
Short InterestHigh
Short % of Float?14.42%High
Short Interest?3.2M
Days to Cover?5.3
Free Float21.9M
Avg Daily Volume597.8K
Settlement Date2026-06-30
Financial Health
Current Ratio?4.71Strong
Quick Ratio?4.71Strong
Cash Ratio?0.92Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?3.76FAIR▾
Peers100
S&P47
P/S?19.69HIGH▾
Peers100
S&P3
P/FCF?13.3CHEAP▾
Peers100
S&P79
EV/EBITDA?-20.3CHEAP▾
S&P97
EV/Sales?18.70HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-9.5%WEAK▾
S&P9
ROA?-6.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$106.9M
Enterprise Value?$1.4B
Fundamentals ratios updated end of day